OncoCyte

Presence

OncoCyte is owned by Lineage Cell Therapeutics.

Lineage Cell Therapeutics is a company listed under the stock ticker LCTX (US).

Lineage Cell Therapeutics has 3 subsidiaries including ESI Bio, OncoCyte and Serina Therapeutics.

Executives

View the org chart displaying its 11 main executives

Most searched biographies at OncoCyte
Popular executive movements at Lineage Cell Therapeutics
  • Charlotte Hubbert has joined the company as Vice President of Corporate Development  (posted on April 2 2024).

Create your alert
to follow the executive moves at OncoCyte.

Biotechnology

Lineage Cell Therapeutics has 2,275 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology
Popular contacts in Biotechnology

Learn more about the Biotechnology industry >

News

Press releases by OncoCyte
Social media about OncoCyte

Get in Touch

Contact by email its executives including Joshua Riggs Premium

Call OncoCyte at +1 510...

View the org chart

Register to receive your alert

Report an error

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.

Individual Access Executive Data Sets
Executives
Companies
The Official Board